News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael H. Davidson, MD, FACC, FACP

Articles by Michael H. Davidson, MD, FACC, FACP

Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice Setting

ByKathleen M. Fox, PhD,Sanjay K. Gandhi, PhD,Robert L. Ohsfeldt, PhD,Michael H. Davidson, MD, FACC, FACP

December 1st 2007

Overview of Prevention and Treatment of Atherosclerosis With Lipid-altering Therapy for Pharmacy Directors

ByMichael H. Davidson, MD, FACC, FACP

December 1st 2007

Latest Updated Articles

Comparison of Low-density Lipoprotein Cholesterol Reduction After Switching Patients on Other Statins to Rosuvastatin or Simvastatin in a Real-world Clinical Practice Setting
Published: December 1st 2007 | Updated:
Overview of Prevention and Treatment of Atherosclerosis With Lipid-altering Therapy for Pharmacy Directors
Published: December 1st 2007 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text